HLA-DR15 Molecules Jointly Shape an Autoreactive T Cell Repertoire in Multiple Sclerosis

HLA-DR15分子共同塑造多发性硬化症中的自身反应性T细胞库

阅读:1
作者:Jian Wang ,Ivan Jelcic ,Lena Mühlenbruch ,Veronika Haunerdinger ,Nora C Toussaint ,Yingdong Zhao ,Carolina Cruciani ,Wolfgang Faigle ,Reza Naghavian ,Magdalena Foege ,Thomas M C Binder ,Thomas Eiermann ,Lennart Opitz ,Laura Fuentes-Font ,Richard Reynolds ,William W Kwok ,Julie T Nguyen ,Jar-How Lee ,Andreas Lutterotti ,Christian Münz ,Hans-Georg Rammensee ,Mathias Hauri-Hohl ,Mireia Sospedra ,Stefan Stevanovic ,Roland Martin

Abstract

The HLA-DR15 haplotype is the strongest genetic risk factor for multiple sclerosis (MS), but our understanding of how it contributes to MS is limited. Because autoreactive CD4+ T cells and B cells as antigen-presenting cells are involved in MS pathogenesis, we characterized the immunopeptidomes of the two HLA-DR15 allomorphs DR2a and DR2b of human primary B cells and monocytes, thymus, and MS brain tissue. Self-peptides from HLA-DR molecules, particularly from DR2a and DR2b themselves, are abundant on B cells and thymic antigen-presenting cells. Furthermore, we identified autoreactive CD4+ T cell clones that can cross-react with HLA-DR-derived self-peptides (HLA-DR-SPs), peptides from MS-associated foreign agents (Epstein-Barr virus and Akkermansia muciniphila), and autoantigens presented by DR2a and DR2b. Thus, both HLA-DR15 allomorphs jointly shape an autoreactive T cell repertoire by serving as antigen-presenting structures and epitope sources and by presenting the same foreign peptides and autoantigens to autoreactive CD4+ T cells in MS.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。